Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does EPOPROSTENOL Cause Dermatitis contact? 190 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 190 reports of Dermatitis contact have been filed in association with EPOPROSTENOL (EPOPROSTENOL). This represents 1.4% of all adverse event reports for EPOPROSTENOL.

190
Reports of Dermatitis contact with EPOPROSTENOL
1.4%
of all EPOPROSTENOL reports
13
Deaths
157
Hospitalizations

How Dangerous Is Dermatitis contact From EPOPROSTENOL?

Of the 190 reports, 13 (6.8%) resulted in death, 157 (82.6%) required hospitalization, and 8 (4.2%) were considered life-threatening.

Is Dermatitis contact Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for EPOPROSTENOL. However, 190 reports have been filed with the FAERS database.

What Other Side Effects Does EPOPROSTENOL Cause?

Dyspnoea (2,744) Headache (2,425) Diarrhoea (2,310) Nausea (2,016) Pain in jaw (1,928) Death (1,362) Flushing (1,256) Fatigue (1,133) Hospitalisation (1,078) Vomiting (1,068)

What Other Drugs Cause Dermatitis contact?

TREPROSTINIL (1,834) DUPILUMAB (358) HUMAN IMMUNOGLOBULIN G (345) ADALIMUMAB (321) ETANERCEPT (170) NICOTINE (163) CALCIUM\DEXTROSE\MAGNESIUM\SODIUM\SODIUM (160) AMBRISENTAN (147) CHLORHEXIDINE\ISOPROPYL ALCOHOL (146) ESTRADIOL (146)

Which EPOPROSTENOL Alternatives Have Lower Dermatitis contact Risk?

EPOPROSTENOL vs EPTIFIBATIDE EPOPROSTENOL vs EPTINEZUMAB-JJMR EPOPROSTENOL vs EPTINEZUMAB\EPTINEZUMAB-JJMR EPOPROSTENOL vs EQUINE BOTULINUM NEUROTOXIN A/B/C/D/E/F/G IMMUNE FAB2 EPOPROSTENOL vs EQUINE THYMOCYTE IMMUNE GLOBULIN

Related Pages

EPOPROSTENOL Full Profile All Dermatitis contact Reports All Drugs Causing Dermatitis contact EPOPROSTENOL Demographics